Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections

Wyeth

Status and phase: Completed; Phase 4

Conditions: Diabetic Foot; Diabetes Mellitus

Treatments: Drug: Piperacillin/Tazobactam

Study type: Interventional

Funder types: Industry

Identifiers

NCT00044746

0910X-100468

Details and patient eligibility

About

Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy and Safety data in Diabetic Inpatients.

Enrollment: 314 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Patients with diabetes mellitus
• Inpatient
• Have 1 or more infected ulcer(s) below the ankle

Exclusion Criteria

• Must not have gangrene or severely impaired arterial supply in your foot
• Must not have a bone infection in the area of your ulcer
• Must not have allergies to penicillins